{"disease":{"id":"primary-immune-deficiency-disorder","name":"primary immune deficiency disorder"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01859754","title":"Octagam 5% Versus Comparator Post Marketing Trial","phase":"","overall_status":"COMPLETED","enrollment_count":623,"lead_sponsor_name":"Octapharma","has_results":false},{"nct_id":"NCT03618147","title":"Primary Immunodeficiency in Kuwait","phase":"","overall_status":"COMPLETED","enrollment_count":314,"lead_sponsor_name":"Kuwait Society for Allergy and Clinical Immunology","has_results":true},{"nct_id":"NCT03414528","title":"Identification of New Inborn Errors of Immunity","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03422614","title":"Pathophysiology of Inborn Immunodeficiencies","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"University of Zurich","has_results":false},{"nct_id":"NCT03939533","title":"Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Octapharma","has_results":true},{"nct_id":"NCT03148028","title":"Immunological Characteristics of Patients With PID and IBD","phase":"","overall_status":"UNKNOWN","enrollment_count":45,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT04197596","title":"Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT01884311","title":"Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Bio Products Laboratory","has_results":true},{"nct_id":"NCT03211689","title":"The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease","phase":"NA","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Stockton University","has_results":false},{"nct_id":"NCT04232085","title":"Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":27,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","has_results":false},{"nct_id":"NCT04354818","title":"Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)","phase":"","overall_status":"UNKNOWN","enrollment_count":27,"lead_sponsor_name":"Kirby Institute","has_results":false},{"nct_id":"NCT03988426","title":"Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Octapharma","has_results":true},{"nct_id":"NCT03266653","title":"EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT03266627","title":"Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT03266640","title":"Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT04414046","title":"TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":17,"lead_sponsor_name":"Johns Hopkins All Children's Hospital","has_results":false},{"nct_id":"NCT03492710","title":"Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Green Cross Corporation","has_results":false}],"total":17},"guidelines":[],"source":"Drug Landscape verified database"}